Koninklijke Philips Gross Profit 2010-2025 | PHG

Koninklijke Philips annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Koninklijke Philips gross profit for the quarter ending March 31, 2025 was $1.948B, a 3.34% increase year-over-year.
  • Koninklijke Philips gross profit for the twelve months ending March 31, 2025 was $8.435B, a 6.78% increase year-over-year.
  • Koninklijke Philips annual gross profit for 2024 was $8.411B, a 4.34% increase from 2023.
  • Koninklijke Philips annual gross profit for 2023 was $8.061B, a 6.35% increase from 2022.
  • Koninklijke Philips annual gross profit for 2022 was $7.58B, a 10.62% decline from 2021.
Koninklijke Philips Annual Gross Profit
(Millions of US $)
2024 $8,411
2023 $8,061
2022 $7,580
2021 $8,480
2020 $10,031
2019 $9,940
2018 $10,101
2017 $9,246
2016 $11,743
2015 $10,944
2014 $10,908
2013 $12,869
2012 $12,101
2011 $12,044
2010 $12,677
2009 $11,267
Koninklijke Philips Quarterly Gross Profit
(Millions of US $)
2025-03-31 $1,948
2024-09-30 $2,206
2024-06-30 $2,142
2023-06-30 $2,139
2023-03-31 $1,885
2022-06-30 $1,843
2021-06-30 $2,156
2020-06-30 $2,016
2019-06-30 $2,389
2018-06-30 $2,392
2017-06-30 $2,118
2016-12-31 $3,472
2016-09-30 $2,904
2016-06-30 $2,867
2016-03-31 $2,500
2015-12-31 $3,101
2015-09-30 $2,695
2015-06-30 $2,760
2015-03-31 $2,388
2014-12-31 $2,730
2014-09-30 $2,422
2014-06-30 $2,991
2014-03-31 $2,766
2013-12-31 $3,906
2013-09-30 $3,122
2013-06-30 $3,065
2013-03-31 $2,775
2012-12-31 $3,851
2012-09-30 $3,265
2012-06-30 $2,509
2012-03-31 $2,783
2011-12-31 $2,950
2011-09-30 $2,735
2011-06-30 $2,940
2011-03-31 $3,301
2010-12-31 $3,754
2010-09-30 $3,011
2010-06-30 $2,911
2010-03-31 $3,019
2009-12-31 $5,210
2009-09-30 $2,898
2009-06-30 $1,586
2009-03-31 $2,148
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.201B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $237.401B 28.55
Boston Scientific (BSX) United States $145.814B 36.50
Stryker (SYK) United States $145.229B 30.37
EssilorLuxottica (ESLOY) France $130.605B 0.00
Medtronic (MDT) Ireland $113.492B 16.09
Lonza Group Ag (LZAGY) Switzerland $51.916B 0.00
Haleon (HLN) United Kingdom $49.556B 28.23
ResMed (RMD) United States $36.981B 27.78
Agilent Technologies (A) United States $33.778B 22.02
GE HealthCare Technologies (GEHC) United States $33.476B 15.89
Terumo (TRUMY) Japan $27.213B 35.35
Insulet (PODD) United States $21.367B 83.87
Zimmer Biomet Holdings (ZBH) United States $18.451B 11.85
Baxter (BAX) United States $16.093B 12.02
Smith & Nephew SNATS (SNN) United Kingdom $13.187B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.325B 22.01
Lantheus Holdings (LNTH) United States $5.545B 13.99
Prestige Consumer Healthcare (PBH) United States $4.207B 18.80
Perrigo (PRGO) Ireland $3.746B 9.49
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.428B 15.61
ICU Medical (ICUI) United States $3.258B 24.02
Envista Holdings (NVST) United States $3.198B 26.58
GN Store Nord (GNNDY) Denmark $2.319B 19.20
QuidelOrtho (QDEL) United States $2.021B 13.90
LeMaitre Vascular (LMAT) United States $1.839B 41.10
AtriCure (ATRC) United States $1.600B 0.00
Acuren (TIC) United States $1.308B 0.00
Neogen (NEOG) United States $1.220B 15.61
AdaptHealth (AHCO) United States $1.187B 12.05
BioLife Solutions (BLFS) United States $1.107B 0.00
Green Thumb Industries (GTBIF) United States $1.061B 23.86
Phibro Animal Health (PAHC) United States $0.993B 12.70
Kestra Medical Technologies (KMTS) United States $0.963B 0.00
InMode (INMD) Israel $0.888B 8.95
CeriBell (CBLL) United States $0.657B 0.00
Evolus (EOLS) United States $0.656B 0.00
Capricor Therapeutics (CAPR) United States $0.637B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Maravai LifeSciences Holdings (MRVI) United States $0.576B 0.00
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Valneva SE (VALN) France $0.523B 0.00
Tilray Brands (TLRY) Canada $0.419B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.92
Aurora Cannabis (ACB) Canada $0.342B 60.90
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Canopy Growth (CGC) Canada $0.281B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.60
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanara MedTech (SMTI) United States $0.255B 0.00
Cresco Labs (CRLBF) United States $0.251B 0.00
Quanterix (QTRX) United States $0.240B 0.00
OraSure Technologies (OSUR) United States $0.219B 0.00
Biote (BTMD) United States $0.216B 6.08
Brainsway (BWAY) Israel $0.216B 57.10
TriSalus Life Sciences (TLSI) United States $0.208B 0.00
Omeros (OMER) United States $0.208B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.18
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.143B 0.00
FitLife Brands (FTLF) United States $0.134B 16.51
Jin Medical (ZJYL) China $0.109B 0.00
MacroGenics (MGNX) United States $0.098B 0.00
Veru (VERU) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.60
Quipt Home Medical (QIPT) United States $0.089B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Zynex (ZYXI) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Nephros (NEPH) United States $0.043B 57.29
United-Guardian (UG) United States $0.038B 13.02
Rockwell Medical (RMTI) United States $0.033B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00